Seeing Through the Haze: Navigating Transactions in Uncertain Times
Recorded On: 10/07/2024
-
Register
- Non-member - $40
- Member - $25
- *Further discounts may apply once you log in.
Economic uncertainty on an industry-wide or even national scale often forces organizations to pivot from standard operating procedure in order to survive - or to thrive. With the cannabis industry as an example, this session will discuss how such uncertainty can impact transactional needs -- from M&A to real estate to financing. Dig into recession-era success stories and examine the ethical and compliance considerations of advising and counseling emerging industries such as cannabis and psychedelics.
Key:
Complete
Next
Failed
Available
LockedLynn Gefen
Chief Legal Officer
TerrAscend
Global Legal Executive with 20+ years of experience advising multi-billion dollar global publicly traded companies in diverse industries who thrives under pressure and propels positive resolutions through negotiation, persuasion and a keen sense of culture. Trusted advisor to key stakeholders including boards of directors and executive management. Results-oriented change agent with demonstrated success in providing pragmatic, efficient and cost controlled business solutions. Top tier law firm experience.
Core Competencies:
• Public Company and Governance
• Corporate Transactions and M&A
• Litigation and Risk Management
• Regulatory Compliance and Compliance Program
• Labor and Employment
• Marketing and Privacy
• Management and Operations
Jonathan Havens
Partner
Saul Ewing LLP
Jonathan Havens is the co-chair of Saul Ewing's Cannabis Law and Food, Beverage & Agribusiness Practices. He also serves as the firm's Baltimore Office Managing Partner. Companies in the cannabis (both hemp and marijuana), life sciences, food and beverage, and cosmetics industries turn to Jonathan for advice on how to get and keep their products on the market.
Since 2019, Chambers USA has recognized Jonathan as a leading lawyer in cannabis law. In 2021, Law360 selected Jonathan as a cannabis law rising star, and in 2018, the National Law Journal named Jonathan to its inaugural Cannabis Law Trailblazers list. He has been quoted by or authored pieces for The New York Times, The Los Angeles Times, Reuters, CNBC, WIRED, MarketWatch, Engadget, Law360, High Times Magazine, and Marijuana Business Daily.
Jonathan counsels clients on regulatory, compliance, enforcement, and transactional matters related to products regulated by the U.S. Food and Drug Administration (FDA), the Federal Trade Commission (FTC), the U.S. Department of Agriculture (USDA), and the U.S. Drug Enforcement Administration (DEA). His experience also includes matters involving the U.S. Consumer Product Safety Commission (CPSC), U.S. Customs and Border Protection (CBP), state and municipal agencies, and state attorneys general.
Jonathan's deep understanding of the complex requirements that govern myriad products is enhanced by his experience working in government and on Capitol Hill. Before entering private practice, Jonathan served as regulatory counsel with the FDA, where he focused on promotion, advertising, and labeling. Prior to law school, Jonathan served as a legislative aide in both the U.S. Senate and U.S. House of Representatives.
